The Pharmaceuticals and Medical Devices Agency (PMDA) has added a new project team titled “Project team for Consideration of Guiding Principles for AI Utilization.” This team is part of the agency’s “Projects Across Multi‑Offices” program and will focus on developing guiding principles for the use of artificial intelligence in pharmaceutical and medical device contexts.
規制動向2026年8月24日•1分で読めます
PMDA Adds Project Team for AI Utilization Guiding Principles
The Pharmaceuticals and Medical Devices Agency (PMDA) announced a new project team to develop guiding principles for AI utilization, listed under its “Projects Across Multi‑Offices” initiative.
PharmaCountryチームがまとめました · 出典： Pharmaceuticals and Medical Devices Agency
評価
(0)
(0)
(0)
(0)
(0)
評価を残す